Evolus, Inc.
EOLSNASDAQHealthcare● Active
$6.73
+$0.06(+0.86%)
Market Cap$443011495
P/E Ratio—
52W High$10.62
52W Low$3.86
Evolus, Inc. (EOLS) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · EOLS · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.30B | $0.27B | $0.20B | $0.15B | $0.10B |
| Cost of Revenue | $0.10B | $0.08B | $0.06B | $0.06B | $0.04B |
| Gross Profit | $0.19B | $0.18B | $0.14B | $0.09B | $0.06B |
| Gross Margin %(computed) | 64.86% | 68.46% | 69.54% | 60.41% | 56.32% |
| Operating Expenses | |||||
| R&D Expenses | $0.01B | $0.01B | $0.02B | $0.01B | $0.00B |
| G&A Expenses | $0.00B | $0.19B | $0.16B | $0.13B | $0.00B |
| Total Operating Expenses | $0.23B | $0.22B | $0.19B | $0.16B | $0.10B |
| Operating Income | ($0.04B) | ($0.03B) | ($0.05B) | ($0.07B) | ($0.04B) |
| Operating Margin %(computed) | -12.65% | -12.92% | -24.36% | -43.96% | -44.55% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.02B | $0.02B | $0.01B | $0.01B | $0.00B |
| Income Before Tax | ($0.05B) | ($0.05B) | ($0.06B) | ($0.07B) | ($0.05B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.05B) | ($0.05B) | ($0.06B) | ($0.07B) | ($0.05B) |
| Net Margin %(computed) | -17.38% | -18.94% | -30.52% | -50.07% | -46.96% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.80 | $-0.81 | $-1.08 | $-1.33 | $-0.94 |
| Wtd Avg Shares | 0.06B | 0.06B | 0.06B | 0.06B | 0.05B |
| EBITDA | ($0.03B) | ($0.03B) | ($0.04B) | ($0.05B) | ($0.04B) |
| EBITDA Margin %(computed) | -9.71% | -9.39% | -20.69% | -36.24% | -39.19% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Evolus, Inc. data
About Evolus, Inc. (EOLS) Income Statement
Evolus, Inc. (EOLS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, EOLS reported revenue of $0.30B, gross profit of $0.19B (gross margin 64.86%), and net income of ($0.05B) — a net profit margin of -17.38%.
Frequently asked questions
EOLS · 4 questionsEvolus, Inc. (EOLS) reported revenue of $0.30B for 2025, up 11.6% year-over-year.
EOLS revenueEOLS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08